As spotlight trains on biopharma diversity, most companies kept their C-suites exactly the same in 2020 — report
The past year has cast a harsh spotlight on the biopharma industry’s lack of diversity. And though most companies list diversity and inclusion as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
